These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1627448)

  • 1. Myocardial perfusion imaging in the diagnosis of coronary artery disease.
    Go RT; MacIntyre WJ; Cook SA; Neumann DR
    Curr Opin Radiol; 1992 Aug; 4(4):23-33. PubMed ID: 1627448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 201Tl myocardial perfusion imaging.
    Verani MS
    Curr Opin Radiol; 1991 Dec; 3(6):797-809. PubMed ID: 1751290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease.
    Go RT; Marwick TH; MacIntyre WJ; Saha GB; Neumann DR; Underwood DA; Simpfendorfer CC
    J Nucl Med; 1990 Dec; 31(12):1899-905. PubMed ID: 2266384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.
    Berman DS; Kiat H; Maddahi J
    Circulation; 1991 Sep; 84(3 Suppl):I7-21. PubMed ID: 1832100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipyridamole myocardial perfusion imaging.
    Leppo JA
    J Nucl Med; 1994 Apr; 35(4):730-3. PubMed ID: 8151403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual isosorbide dinitrate to improve technetium-99m-teboroxime perfusion defect reversibility.
    Bisi G; Sciagrà R; Santoro GM; Zerauschek F; Fazzini PF
    J Nucl Med; 1994 Aug; 35(8):1274-8. PubMed ID: 8046478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of myocardial perfusion defect size after early and delayed SPECT imaging with technetium-99m-hexakis 2-methoxyisobutyl isonitrile after stress.
    Villanueva-Meyer J; Mena I; Diggles L; Narahara KA
    J Nucl Med; 1993 Feb; 34(2):187-92. PubMed ID: 8429335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential and limitations of Tc-99m sestamibi scintigraphy for the diagnosis of myocardial viability.
    Cornel JH; Arnese M; Forster T; Postma-Tjoa J; Reijs AE; Fioretti PM
    Herz; 1994 Feb; 19(1):19-27. PubMed ID: 8150411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive assessment of coronary collaterals in man by PET perfusion imaging.
    Demer LL; Gould KL; Goldstein RA; Kirkeeide RL
    J Nucl Med; 1990 Mar; 31(3):259-70. PubMed ID: 2307996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radionuclide methods of identifying patients who may require coronary artery bypass surgery.
    Beller GA; Gibson RS; Watson DD
    Circulation; 1985 Dec; 72(6 Pt 2):V9-22. PubMed ID: 3905063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of differential post-stenotic myocardial technetium-99m-teboroxime clearance kinetics after experimental ischemia and hyperemic stress.
    Stewart RE; Heyl B; O'Rourke RA; Blumhardt R; Miller DD
    J Nucl Med; 1991 Oct; 32(10):2000-8. PubMed ID: 1919745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac applications of positron-emission tomography.
    Beanlands R; Schwaiger M
    Curr Opin Radiol; 1991 Dec; 3(6):817-27. PubMed ID: 1751292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography in clinical cardiology.
    Brunken RC; Schelbert HR
    Cardiol Clin; 1989 Aug; 7(3):607-29. PubMed ID: 2670229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfusion imaging in ischemic heart disease.
    Rivitz SM; Deluca SA
    Am Fam Physician; 1993 Nov; 48(6):1071-8. PubMed ID: 8237730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-photon perfusion imaging for the assessment of myocardial viability.
    Hendel RC
    J Nucl Med; 1994 Apr; 35(4 Suppl):23S-31S. PubMed ID: 8151409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic analysis of clinical positron emission tomography of the heart with rubidium-82.
    Gould KL; Goldstein RA; Mullani NA
    J Nucl Med; 1989 May; 30(5):707-17. PubMed ID: 2785587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teboroxime, sestamibi and thallium-201 as markers of myocardial hypoperfusion: comparison by quantitative dual-isotope autoradiography in rabbits.
    Weinstein H; Reinhardt CP; Leppo JA
    J Nucl Med; 1993 Sep; 34(9):1510-7. PubMed ID: 8355072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Scintigraphy and positron emission tomography].
    Kaufmann PA
    Ther Umsch; 1997 Dec; 54(12):711-21. PubMed ID: 9465749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of myocardial viability with 99mTc-labelled myocardial perfusion agents.
    Bisi G; Podio V; Sciagrà R
    Q J Nucl Med; 1996 Mar; 40(1):68-75. PubMed ID: 8681015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.